# Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects

> **NCT00976443** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 60 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** BTA
- **DRUG:** Placebo (normal saline)

## Key facts

- **NCT ID:** NCT00976443
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976443, "Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00976443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*